N-(2-Hydroxypropyl)methacrylamide Copolymer-9-Aminocamptothecin Conjugate: Colon-Specific Drug Delivery in Rats
Source abstract
Abstract
An N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugate containing 9-aminocamptothecin (9-AC) boundvia a spacer containing an aromatic azo bond and leucylalanine (P-Azo-Leu-Ala-9-AC) was synthesized. The in vivo pharmacokinetic profile after oral administration was examined in rats and comparedto free 9-AC. The aromatic azo bond of P-Azo-Leu-Ala-9-AC was stable in stomach and small intestine; the delivery of a large amount of intact conjugate to the colon was achieved. In the colon, the azoreductase activity first cleaved the azo bond followed by peptidase catalyzed cleavage of the leucylalanyl drug derivative resulting in the release of free 9-AC. However, the release rate from the conjugate was not fast enough to achieve high colon concentrations of free 9-AC. The results of the study suggest design features for the second generation of conjugates, including the use of a side-chain with a higher cleavage rate in the colon, combined with the incorporation of bioadhesion technology, to increase colon transit time.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer therapeutics and mechanisms · Neutropenia and Cancer Infections · Intraperitoneal and Appendiceal Malignancies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics and Pharmaceutical Chemistry, Salt Lake City, Utah 84112, USA
Department of Bioengineering, University of Utah, Salt Lake City, Utah 84112, USA
References (49)
Show source-provided references
1. 10.3322/canjclin.47.1.510.3322/canjclin.47.1.5 ↗
2. 10.1097/00001813-199608000-0000110.1097/00001813-199608000-00001 ↗
3. 10.1093/annonc/5.suppl_3.S11510.1093/annonc/5.suppl_3.S115 ↗
4. 10.1002/(SICI)1097-0142(19971101)80:9<1727::AID-CNCR5>3.0.CO;2-B10.1002/(SICI)1097-0142(19971101)80:9<1727::AID-CNCR5>3.0.CO;2-B ↗
5. Rothenberg, M.L. · Semin. Oncol. · 1999 · 26 · 632
6. 10.1007/BF0204844010.1007/BF02048440 ↗
7. 10.1111/j.1749-6632.1996.tb26393.x10.1111/j.1749-6632.1996.tb26393.x ↗
8. 10.1126/science.255592010.1126/science.2555920 ↗
9. Pantazis, P. · Oncol. Res. · 1993 · 5 · 273
10. De Souza, P.L. · Clin. Cancer Res. · 1997 · 3 · 287
11. Muggia, F.M. · Clin. Cancer Res. · 2001 · 7 · 168
12. 10.1111/j.1749-6632.1996.tb26395.x10.1111/j.1749-6632.1996.tb26395.x ↗
13. 10.1200/JCO.1997.15.8.290510.1200/JCO.1997.15.8.2905 ↗
14. Supko, J.G. · Cancer Res. · 1993 · 53 · 3062
15. 10.1200/JCO.1997.15.4.149210.1200/JCO.1997.15.4.1492 ↗
16. Kirstein, M.N. · Clin. Cancer Res. · 2001 · 7 · 358
17. 10.1615/CritRevTherDrugCarrierSyst.v17.i6.1010.1615/CritRevTherDrugCarrierSyst.v17.i6.10 ↗
18. 10.1023/A:101103312152810.1023/A:1011033121528 ↗
19. 10.1002/(SICI)1521-3935(19981101)199:11<2601::AID-MACP2601>3.0.CO;2-910.1002/(SICI)1521-3935(19981101)199:11<2601::AID-MACP2601>3.0.CO;2-9 ↗
20. 10.1002/1097-4636(20000905)51:3<329::AID-JBM6>3.0.CO;2-010.1002/1097-4636(20000905)51:3<329::AID-JBM6>3.0.CO;2-0 ↗
21. 10.1021/bc990098a10.1021/bc990098a ↗
22. 10.1172/JCI11770010.1172/JCI117700 ↗
23. 10.1002/ijc.291045041610.1002/ijc.2910450416 ↗
24. Yuan, M. · Cancer Res. · 1986 · 46 · 4841
25. 10.1016/0168-3659(94)90168-610.1016/0168-3659(94)90168-6 ↗
26. Grim, Y. · New Polymeric Mat. · 1991 · 3 · 49
27. 10.1002/macp.1990.02191090610.1002/macp.1990.021910906 ↗
28. 10.1126/science.352655310.1126/science.3526553 ↗
29. 10.1016/S0168-3659(01)00405-910.1016/S0168-3659(01)00405-9 ↗
30. 10.1016/0014-3057(73)90063-310.1016/0014-3057(73)90063-3 ↗
31. 10.1002/macp.1977.02178080310.1002/macp.1977.021780803 ↗
32. 10.1002/ijc.291061021410.1002/ijc.2910610214 ↗
33. 10.1080/00365529975002473310.1080/003655299750024733 ↗
34. 10.1177/01486071980220011410.1177/014860719802200114 ↗
35. 10.1159/00019729810.1159/000197298 ↗
36. 10.1038/bjc.1975.13410.1038/bjc.1975.134 ↗
37. Kim, Y.-I. · Am. J. Pathol. · 1996 · 149 · 1129
38. 10.1016/0378-4347(94)00051-410.1016/0378-4347(94)00051-4 ↗
39. 10.1002/jlb.52.4.37710.1002/jlb.52.4.377 ↗
40. 10.1016/0306-4522(92)90482-H10.1016/0306-4522(92)90482-H ↗
41. 10.1016/S0939-6411(00)00075-810.1016/S0939-6411(00)00075-8 ↗
42. 42. Kopeček, J. and Kopečková, P. (1992). In: Friend, D.R. (ed.), Oral Colon-Specific Drug Delivery, p. 189-189, CRC Press, Boca Raton, Boca Raton.
43. 10.1002/macp.1992.02193101010.1002/macp.1992.021931010 ↗
44. 10.1021/bc000080w10.1021/bc000080w ↗
45. 10.1007/s00280005078910.1007/s002800050789 ↗
46. Sparreboom, A. · Clin. Cancer Res. · 1998 · 4 · 1915
47. 47. Gao, S.Q., Lu, Z.R., Kopečková, P. and Kopeček, J. (2002). In preparation.
48. 10.1083/jcb.98.2.39910.1083/jcb.98.2.399 ↗
49. 10.1007/BF0153698810.1007/BF01536988 ↗